Introduction
Begin by contextualizing Dr. Gogia’s passion and expertise in precision-driven care of blood cancers like lymphoma, CLL, multiple myeloma. Highlight his leadership of dedicated clinics and over a decade of real-world clinical research.
What Is Precision Oncology?
- Explain in clear terms how tumor profiling (genetic, molecular) enables tailored therapy, improving effectiveness while minimizing side effects—akin to Cancer Consult India’s “targeted therapy” narratives.
- Add a case example: a lymphoma patient profiled for biomarkers, given a specific targeted agent, resulting in impressive remission.
Cutting-Edge Tools & Techniques
- Molecular diagnostics (NGS panels, FISH, IHC etc.)
- Risk-scoring models like AMOS/AMES for prognostication.
- How Dr. Gogia applies evidence from global trials to Indian patient cohorts.
Therapies and Research
- Breakthroughs such as CAR-T cells, BTK inhibitors, BCL‑2 inhibitors, monoclonal antibodies, with simplified explanations.
- Summarize key clinical results and how Dr. Gogia adapts them for his patients, similar to summaries seen in Cancer Consult content about immunotherapy advancements.
Patient Outcomes & Quality of Life
- Example of a multiple myeloma patient living well on oral targeted therapy.
- Emphasize side effect management, regular monitoring, and the importance of holistic support.
Who Should Consider Precision Therapy?
- Outline eligibility criteria (e.g., relapsed or refractory cases, presence of actionable genetic mutations).
- Dr. Gogia’s assessments and consultation process.
How to Engage at AIIMS
- OPD timings, contact pathways.
- Encourage early evaluation: “If you or your loved one has been diagnosed with lymphoma, CLL, or myeloma—schedule a visit to explore precision-targeted options.”